Lafond Kevin G 4
4 · ZIOPHARM ONCOLOGY INC · Filed Jan 3, 2018
Insider Transaction Report
Form 4
Lafond Kevin G
Vice Pres., Treasurer, & CAO
Transactions
- Award
Common Stock
2017-12-29+53,000→ 110,967 total - Tax Payment
Common Stock
2017-12-30$4.14/sh−13,100$54,234→ 97,867 total - Tax Payment
Common Stock
2017-12-31$4.14/sh−9,333$38,639→ 88,534 total
Footnotes (2)
- [F1]17,666 shares shall vest on 12/29/2018; 17,667 shares shall vest on each of 12/29/2019 and 12/29/2020.
- [F2]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.